Article | July 8, 2026

Technology Transfer: Best Practices For Optimizing Success And Mitigating Risk In Sterile Drug Manufacturing

sterile-pharma-manufacturing-GettyImages-2197041330

Technology transfer is a critical yet complex phase in sterile drug manufacturing, where missteps can impact timelines, costs, and product quality. Success depends on early alignment, structured planning, and clear communication across all stakeholders. Strong project teams — defined by clear roles, cross-functional expertise, and proactive risk management — help ensure seamless execution and consistent outcomes.

A strategic approach integrates detailed timelines, data-sharing tools, and flexible frameworks such as stage-gate processes to manage evolving project demands. Applying structured methodologies like the 7M framework enables teams to anticipate challenges, optimize resources, and address risks before they escalate.

With increasing demand for sterile manufacturing, organizations that prioritize collaboration, contingency planning, and global coordination are better positioned to accelerate transfers while maintaining compliance and quality. Gain practical insights to strengthen your technology transfer strategy and minimize risk across every stage of development.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online